Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Garst

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Therapeutics and Clinical Risk Management|June 3, 2008
Topotecan: An evolving option in the treatment of relapsed small cell lung cancerJennifer Garst
Expert Opinion on Drug Safety|December 22, 2006
Safety of topotecan in the treatment of recurrent small-cell lung cancer and ovarian cancerJennifer Garst
Current Oncology Reports|June 26, 2007
Vaccine therapy in non-small-cell lung cancerCarol Albright, Jennifer Garst
Current Oncology Reports|June 11, 2005
Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancerBrian J Byrne, Jennifer Garst
Current Oncology Reports|January 27, 2007
Lung cancer in womenAngela M Coscio, Jennifer Garst
Clinical Lung Cancer|December 16, 2005
Topotecan in the treatment of elderly patients with relapsed small-cell lung cancerJennifer Garst, Richard Buller, Stephen Lane, et al.
Current Oncology Reports|January 27, 2007
Genomic signatures in non-small-cell lung cancer: targeting the targeted therapiesHolly K Dressman, Andrea Bild, Jennifer Garst, et al.
The American Journal of Psychology|January 9, 2003
Satisficing in hypothesis generationJennifer Garst, Norbert L Kerr, Susan E Harris, et al.
Pain|October 19, 2007
Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distressLaura S Porter, Francis J Keefe, Jennifer Garst, et al.
Cancer|March 8, 2005
Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group BGerald Clamon, James Herndon, Jeffrey Kern, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Therapeutics and Clinical Risk Management|June 3, 2008
Topotecan: An evolving option in the treatment of relapsed small cell lung cancerJennifer Garst
Expert Opinion on Drug Safety|December 22, 2006
Safety of topotecan in the treatment of recurrent small-cell lung cancer and ovarian cancerJennifer Garst
Current Oncology Reports|June 26, 2007
Vaccine therapy in non-small-cell lung cancerCarol Albright, Jennifer Garst
Current Oncology Reports|June 11, 2005
Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancerBrian J Byrne, Jennifer Garst
Current Oncology Reports|January 27, 2007
Lung cancer in womenAngela M Coscio, Jennifer Garst
Clinical Lung Cancer|December 16, 2005
Topotecan in the treatment of elderly patients with relapsed small-cell lung cancerJennifer Garst, Richard Buller, Stephen Lane, et al.
Current Oncology Reports|January 27, 2007
Genomic signatures in non-small-cell lung cancer: targeting the targeted therapiesHolly K Dressman, Andrea Bild, Jennifer Garst, et al.
The American Journal of Psychology|January 9, 2003
Satisficing in hypothesis generationJennifer Garst, Norbert L Kerr, Susan E Harris, et al.
Pain|October 19, 2007
Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distressLaura S Porter, Francis J Keefe, Jennifer Garst, et al.
Cancer|March 8, 2005
Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group BGerald Clamon, James Herndon, Jeffrey Kern, et al.
Pageof 4